These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34497457)

  • 1. Evaluation of the Multiple Sclerosis Spasticity Scale 88: A Short Report.
    Freeman J; Gorst T; Ofori J; Marsden J
    Rehabil Process Outcome; 2019; 8():1179572718823510. PubMed ID: 34497457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cross-cultural adaptation and psychometric validation of the MSSS-88 for use in Italian patients with multiple sclerosis.
    Ottonello M; Pellicciari L; Centonze D; Foti C; Pistarini C; Albensi C; Giordano A
    Disabil Rehabil; 2019 Feb; 41(4):465-471. PubMed ID: 29069950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Getting the measure of spasticity in multiple sclerosis: the Multiple Sclerosis Spasticity Scale (MSSS-88).
    Hobart JC; Riazi A; Thompson AJ; Styles IM; Ingram W; Vickery PJ; Warner M; Fox PJ; Zajicek JP
    Brain; 2006 Jan; 129(Pt 1):224-34. PubMed ID: 16280352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the Serbian Version of Multiple Sclerosis Spasticity Scale 88 (MSSS-88).
    Rodic SZ; Knezevic TI; Kisic-Tepavcevic DB; Dackovic JR; Dujmovic I; Pekmezovic TD; Drulovic JS; Konstantinovic LM
    PLoS One; 2016; 11(1):e0147042. PubMed ID: 26771661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linguistic and psychometric validation of the MSSS-88 questionnaire for patients with multiple sclerosis and spasticity in Germany.
    Henze T; von Mackensen S; Lehrieder G; Zettl UK; Pfiffner C; Flachenecker P
    Health Qual Life Outcomes; 2014 Aug; 12():119. PubMed ID: 25080934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 88-item Multiple Sclerosis Spasticity Scale: a Rasch validation of the Italian version and suggestions for refinement of the original scale.
    Pellicciari L; Ottonello M; Giordano A; Albensi C; Franchignoni F
    Qual Life Res; 2019 Jan; 28(1):221-231. PubMed ID: 30238266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plantarflexor weakness negatively impacts walking in persons with multiple sclerosis more than plantarflexor spasticity.
    Wagner JM; Kremer TR; Van Dillen LR; Naismith RT
    Arch Phys Med Rehabil; 2014 Jul; 95(7):1358-65. PubMed ID: 24582617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot study of a comparison between a patient scored numeric rating scale and clinician scored measures of spasticity in multiple sclerosis.
    Anwar K; Barnes MP
    NeuroRehabilitation; 2009; 24(4):333-40. PubMed ID: 19597271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in the management of multiple sclerosis symptoms: pathophysiology and assessment of spasticity in multiple sclerosis.
    Tintoré M
    Neurodegener Dis Manag; 2015; 5(6 Suppl):15-7. PubMed ID: 26611266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamometer-based measure of spasticity confirms limited association between plantarflexor spasticity and walking function in persons with multiple sclerosis.
    Kremer TR; Van Dillen LR; Wagner JM
    J Rehabil Res Dev; 2014; 51(6):975-84. PubMed ID: 25356797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity and reliability of the Serbian version of Patient-Reported Impact of Spasticity Measure in multiple sclerosis.
    Knezevic T; Konstantinovic L; Rodic S; Foti C; Drulovic J; Dackovic J; Nikolic D; Petronic I; Stokic DS
    Int J Rehabil Res; 2015 Sep; 38(3):199-205. PubMed ID: 25603541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A group-delivered self-management program reduces spasticity in people with multiple sclerosis: A randomized, controlled pilot trial.
    Hugos CL; Bourdette D; Chen Y; Chen Z; Cameron M
    Mult Scler J Exp Transl Clin; 2017; 3(1):2055217317699993. PubMed ID: 28607753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment and Measurement of Spasticity in MS: State of the Evidence.
    Hugos CL; Cameron MH
    Curr Neurol Neurosci Rep; 2019 Aug; 19(10):79. PubMed ID: 31471769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validity, reliability, and clinical importance of change in a 0-10 numeric rating scale measure of spasticity: a post hoc analysis of a randomized, double-blind, placebo-controlled trial.
    Farrar JT; Troxel AB; Stott C; Duncombe P; Jensen MP
    Clin Ther; 2008 May; 30(5):974-85. PubMed ID: 18555944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The symptom inventory disability-specific short forms for multiple sclerosis: construct validity, responsiveness, and interpretation.
    Schwartz CE; Bode RK; Quaranto BR; Vollmer T
    Arch Phys Med Rehabil; 2012 Sep; 93(9):1617-1628.e1. PubMed ID: 22580198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perceived impact of spasticity is associated with spatial and temporal parameters of gait in multiple sclerosis.
    Balantrapu S; Sandroff BM; Sosnoff JJ; Motl RW
    ISRN Neurol; 2012; 2012():675431. PubMed ID: 22462022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of spasticity on mobility and balance in persons with multiple sclerosis.
    Sosnoff JJ; Gappmaier E; Frame A; Motl RW
    J Neurol Phys Ther; 2011 Sep; 35(3):129-32. PubMed ID: 21934374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vibration therapy in multiple sclerosis: a pilot study exploring its effects on tone, muscle force, sensation and functional performance.
    Schyns F; Paul L; Finlay K; Ferguson C; Noble E
    Clin Rehabil; 2009 Sep; 23(9):771-81. PubMed ID: 19561035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
    Shaw L; Rodgers H; Price C; van Wijck F; Shackley P; Steen N; Barnes M; Ford G; Graham L;
    Health Technol Assess; 2010 May; 14(26):1-113, iii-iv. PubMed ID: 20515600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anodal transcranial direct current stimulation of motor cortex does not ameliorate spasticity in multiple sclerosis.
    Iodice R; Dubbioso R; Ruggiero L; Santoro L; Manganelli F
    Restor Neurol Neurosci; 2015; 33(4):487-92. PubMed ID: 26409407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.